Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Xa Activity”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Post-approval studies (Phase 4)Study completedNCT01687491
What this trial is testing

Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeFactor X
Les Laboratoires des Médicaments Stériles 179
Not applicableUnknownNCT04671160
What this trial is testing

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Who this might be right for
Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
Medical University of Gdansk 80
Not applicableStudy completedNCT02925247
What this trial is testing

Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients

Who this might be right for
Atrial Fibrillation
Assistance Publique Hopitaux De Marseille 150
Post-approval studies (Phase 4)Ended earlyNCT03296033
What this trial is testing

Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

Who this might be right for
Anticoagulants and Bleeding DisordersSurgeryRegional Anesthesia Morbidity
Wake Forest University Health Sciences 122
Post-approval studies (Phase 4)Study completedNCT05672550
What this trial is testing

Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)

Who this might be right for
Pediatric Kidney Transplant Recipients
Assistance Publique - Hôpitaux de Paris 50
Post-approval studies (Phase 4)Enrolling By InvitationNCT06862726
What this trial is testing

Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation

Who this might be right for
Non Valvular Atrial Fibrillation
Les Laboratoires des Médicaments Stériles 120
Not applicableLooking for participantsNCT07200674
What this trial is testing

Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma

Who this might be right for
Hypertriglyceridemia
University Hospital, Strasbourg, France 150
Not applicableStudy completedNCT01064596
What this trial is testing

Fondaparinux Population Pharmacokinetic to Morbid Obese Patients in Post-operatory Bariatric Surgery

Who this might be right for
Morbid ObesityObesitySurgery
Centre Hospitalier Universitaire de Saint Etienne 40
Large-scale testing (Phase 3)Study completedNCT02073682
What this trial is testing

Cancer Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+1 more
Daiichi Sankyo 1,046
Early research (Phase 1)Study completedNCT00618579
What this trial is testing

Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin

Who this might be right for
Healthy
ThromboGenics 15
Not applicableUnknownNCT06431789
What this trial is testing

Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

Who this might be right for
Gene PolymorphismEdoxabanRenal Insufficiency
Yi Han 220
Post-approval studies (Phase 4)UnknownNCT02295150
What this trial is testing

Prophylaxis of Venous Thromboembolism After Bariatric Surgery

Who this might be right for
Morbid ObesityThromboembolismBypass Complications
Rijnstate Hospital 50
Large-scale testing (Phase 3)Study completedNCT02746185
What this trial is testing

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

Who this might be right for
NeoplasmVenous Thromboembolism
Assistance Publique - Hôpitaux de Paris 159
Not applicableWithdrawnNCT05554055
What this trial is testing

Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)

Who this might be right for
Aortic DiseasesArterial DiseaseThrombosis
Hospices Civils de Lyon
Not applicableLooking for participantsNCT07183605
What this trial is testing

Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients

Who this might be right for
Anticoagulants and Bleeding Disorders
Centre Hospitalier Régional d'Orléans 30
Not applicableStudy completedNCT02333929
What this trial is testing

Validation of Rivaroxaban Assay for US Registration

Who this might be right for
Patients Receiving Rivaroxaban Treatment
Diagnostica Stago 100
Large-scale testing (Phase 3)Study completedNCT00311090
What this trial is testing

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs

Who this might be right for
Deep Venous Thrombosis
Sanofi 757
Not applicableLooking for participantsNCT06357403
What this trial is testing

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients

Who this might be right for
ThrombosisPulmonary EmbolismEnoxaparin
Medical University of Vienna 1,300
Post-approval studies (Phase 4)Study completedNCT03363035
What this trial is testing

Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionMyocardial Ischemia+1 more
Second Xiangya Hospital of Central South University 2,055
Not applicableLooking for participantsNCT07302620
What this trial is testing

HEPARINS: INTERFERENCE IN ARGATROBAN MEASUREMENT

Who this might be right for
Thromboembolic Disease
University Hospital, Strasbourg, France 70
Next Page